Patents by Inventor Jacob Thorhauge

Jacob Thorhauge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxamic acid esters and pharmaceutical use thereof
    Patent number: 8034811
    Abstract: The invention relates to compounds of general formula I wherein D, E, F, G, W, Y, R1, A, R9, X, B, R8 are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer.
    Type: Grant
    Filed: December 2, 2004
    Date of Patent: October 11, 2011
    Assignee: Leo Pharma A/S
    Inventors: Jef Fensholdt, Jacob Thorhauge, Bjarne Nørremark
  • Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
    Publication number: 20070244117
    Abstract: The invention relates to compounds of general formula I wherein D, E, F, G, W, Y, R1, A, R9, X, B, R8 are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer.
    Type: Application
    Filed: December 2, 2004
    Publication date: October 18, 2007
    Applicant: Leo Pharma A/S
    Inventors: Jef Fensholdt, Jacob Thorhauge, Bjarne Norremark
  • Novel fusidic acid derivatives
    Publication number: 20070105826
    Abstract: Fusidic acid derivatives substituted at C-24 may be used in therapy for the treatment of infections.
    Type: Application
    Filed: July 9, 2004
    Publication date: May 10, 2007
    Applicant: LEO PHARMA A/S
    Inventors: Tore Duvold, Claus Svensgaard Bretting, Poul Rasmussen, Laetitia Duvold, Jacob Thorhauge